Half of Older Women Suffer Incontinence, Many Don't Tell Their Doc

Title: Half of Older Women Suffer Incontinence, Many Don't Tell Their DocCategory: Health NewsCreated: 11/1/2018 12:00:00 AMLast Editorial Review: 11/1/2018 12:00:00 AM
Source: MedicineNet Womens Health General - Category: OBGYN Source Type: news

Related Links:

ConclusionsTo the best of our knowledge, this is the first case of MDEM in which the two episodes of ADEM occurred 8 years apart. Although this case fulfills the diagnostic criteria for MDEM, the time elapsed between the two episodes is very long. Therefore, we cannot exclude that this disease might be a new nosological entity that could be included in the expanding range of demyelinating diseases.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
AbstractIntroduction and hypothesisOur aim was to assess whether immediate preoperative resident simulation training decreases operative time and improves resident proficiency when performing a retropubic midurethral sling (MUS) procedure.MethodsThis prospective cohort study took place over 8  months at the Icahn School of Medicine, New York, USA. During the first 4 months, all retropubic MUS procedures were performed by residents who underwent immediate preoperative simulation training. The cases completed during the following 4 months were performed by residents who had not received preoperative simulation...
Source: International Urogynecology Journal - Category: OBGYN Source Type: research
AbstractIntroduction and hypothesisMidurethral slings (MUS) are an established treatment for stress urinary incontinence (SUI), with good objective outcomes and low rates of complications. However, large population-based registry studies highlighted long-term complications from polypropylene slings including erosion, dyspareunia and chronic pain. With recent highly negative media coverage, many women are presenting with chronic pain attributed to the mesh to request complete removal. The available literature provides limited evidence on safety, symptom resolution and incontinence following MUS removal.MethodsWe identified ...
Source: International Urogynecology Journal - Category: OBGYN Source Type: research
Conditions:   Urinary Incontinence;   Menopause Interventions:   Drug: Testosterone Enanthate;   Drug: Placebo Sponsor:   Brigham and Women's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Stress Urinary Incontinence Interventions:   Device: Vesair Balloon;   Other: Sham balloon placement Sponsor:   Solace Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Fecal Incontinence Intervention:   Device: leva Sponsor:   Renovia, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Urinary Incontinence;   Menopause Interventions:   Drug: Testosterone Enanthate;   Drug: Placebo Sponsor:   Brigham and Women's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Stress Urinary Incontinence Interventions:   Device: Vesair Balloon;   Other: Sham balloon placement Sponsor:   Solace Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Urinary Incontinence;   Menopause Interventions:   Drug: Testosterone Enanthate;   Drug: Placebo Sponsor:   Brigham and Women's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Stress Urinary Incontinence Interventions:   Device: Vesair Balloon;   Other: Sham balloon placement Sponsor:   Solace Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Incontinence | OBGYN | Women